Overview
Satoyoshi syndrome (also known as Satoyoshi disease or komuragaeri disease) is an extremely rare multisystem disorder of presumed autoimmune origin, first described by Eijiro Satoyoshi in 1978. The condition is characterized by progressive, painful intermittent muscle spasms (komuragaeri), alopecia universalis (complete hair loss), diarrhea or other gastrointestinal disturbances, and skeletal abnormalities including osteolytic lesions and short stature due to epiphyseal destruction. The muscle spasms typically begin in the legs and may spread to involve the trunk, arms, and masticatory muscles, often severely impairing mobility and quality of life. Secondary amenorrhea is frequently observed in affected females. Endocrine abnormalities, including glucose intolerance, may also be present. The disease predominantly affects children and adolescents, with onset typically occurring between the ages of 6 and 15 years. It appears to occur more frequently in females and has been reported predominantly in individuals of Japanese descent, though cases have been described in other ethnic groups worldwide. The pathogenesis is not fully understood, but an autoimmune mechanism is strongly suspected based on the presence of autoantibodies and the association with other autoimmune conditions in some patients. Treatment is primarily symptomatic and supportive. Muscle relaxants such as dantrolene sodium have been used with some success to control the painful spasms. Corticosteroids and other immunosuppressive therapies have shown benefit in some cases, supporting the autoimmune hypothesis. Bisphosphonates may be considered for skeletal involvement. Early treatment may help prevent progressive skeletal deformities. The prognosis is variable; while the condition can be debilitating, some patients respond well to treatment. No curative therapy currently exists, and long-term management requires a multidisciplinary approach involving neurology, rheumatology, endocrinology, and orthopedics.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Satoyoshi syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Satoyoshi syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Satoyoshi syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Satoyoshi syndrome.
Community
No community posts yet. Be the first to share your experience with Satoyoshi syndrome.
Start the conversation →Latest news about Satoyoshi syndrome
No recent news articles for Satoyoshi syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Satoyoshi syndrome
What is Satoyoshi syndrome?
Satoyoshi syndrome (also known as Satoyoshi disease or komuragaeri disease) is an extremely rare multisystem disorder of presumed autoimmune origin, first described by Eijiro Satoyoshi in 1978. The condition is characterized by progressive, painful intermittent muscle spasms (komuragaeri), alopecia universalis (complete hair loss), diarrhea or other gastrointestinal disturbances, and skeletal abnormalities including osteolytic lesions and short stature due to epiphyseal destruction. The muscle spasms typically begin in the legs and may spread to involve the trunk, arms, and masticatory muscles
How is Satoyoshi syndrome inherited?
Satoyoshi syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Satoyoshi syndrome typically begin?
Typical onset of Satoyoshi syndrome is childhood. Age of onset can vary across affected individuals.